327 related articles for article (PubMed ID: 34923737)
1. DNA damage response proteins in canine cancer as potential research targets in comparative oncology.
Hernández-Suárez B; Gillespie DA; Pawlak A
Vet Comp Oncol; 2022 Jun; 20(2):347-361. PubMed ID: 34923737
[TBL] [Abstract][Full Text] [Related]
2. DNA damage response and DNA repair - dog as a model?
Grosse N; van Loon B; Rohrer Bley C
BMC Cancer; 2014 Mar; 14():203. PubMed ID: 24641873
[TBL] [Abstract][Full Text] [Related]
3. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
Arjumand W; Asiaf A; Ahmad ST
Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
[TBL] [Abstract][Full Text] [Related]
4. Multiple roles of BRIT1/MCPH1 in DNA damage response, DNA repair, and cancer suppression.
Lin SY; Liang Y; Li K
Yonsei Med J; 2010 May; 51(3):295-301. PubMed ID: 20376879
[TBL] [Abstract][Full Text] [Related]
5. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937
[TBL] [Abstract][Full Text] [Related]
6. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
[TBL] [Abstract][Full Text] [Related]
7. Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.
Wu Z; Li S; Tang X; Wang Y; Guo W; Cao G; Chen K; Zhang M; Guan M; Yang D
Theranostics; 2020; 10(9):3939-3951. PubMed ID: 32226530
[No Abstract] [Full Text] [Related]
8. Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy.
Thumser-Henner P; Nytko KJ; Rohrer Bley C
BMC Vet Res; 2020 Jan; 16(1):30. PubMed ID: 32005245
[TBL] [Abstract][Full Text] [Related]
9. DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'.
Bartek J; Lukas J; Bartkova J
Cell Cycle; 2007 Oct; 6(19):2344-7. PubMed ID: 17700066
[TBL] [Abstract][Full Text] [Related]
10. Alterations in DNA Damage Repair Genes in Primary Liver Cancer.
Lin J; Shi J; Guo H; Yang X; Jiang Y; Long J; Bai Y; Wang D; Yang X; Wan X; Zhang L; Pan J; Hu K; Guan M; Huo L; Sang X; Wang K; Zhao H
Clin Cancer Res; 2019 Aug; 25(15):4701-4711. PubMed ID: 31068370
[TBL] [Abstract][Full Text] [Related]
11. Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP).
Rosen DB; Leung LY; Louie B; Cordeiro JA; Conroy A; Shapira I; Fields SZ; Cesano A; Hawtin RE
J Transl Med; 2014 Jun; 12():184. PubMed ID: 24965603
[TBL] [Abstract][Full Text] [Related]
12. DNA damage response pathways in tumor suppression and cancer treatment.
Liang Y; Lin SY; Brunicardi FC; Goss J; Li K
World J Surg; 2009 Apr; 33(4):661-6. PubMed ID: 19034564
[TBL] [Abstract][Full Text] [Related]
13. Targeting the DNA damage response in oncology: past, present and future perspectives.
Basu B; Yap TA; Molife LR; de Bono JS
Curr Opin Oncol; 2012 May; 24(3):316-24. PubMed ID: 22476188
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
15. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.
Jiang M; Jia K; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; He Y; Zhou C
Acta Pharm Sin B; 2021 Oct; 11(10):2983-2994. PubMed ID: 34729299
[TBL] [Abstract][Full Text] [Related]
16. PIK3CA mutations matter for cancer in dogs.
Kim JH
Res Vet Sci; 2020 Dec; 133():39-41. PubMed ID: 32932196
[TBL] [Abstract][Full Text] [Related]
17. Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.
Basourakos SP; Li L; Aparicio AM; Corn PG; Kim J; Thompson TC
Curr Med Chem; 2017; 24(15):1586-1606. PubMed ID: 27978798
[TBL] [Abstract][Full Text] [Related]
18. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
Nepomuceno TC; De Gregoriis G; de Oliveira FMB; Suarez-Kurtz G; Monteiro AN; Carvalho MA
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858227
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic opportunities within the DNA damage response.
Pearl LH; Schierz AC; Ward SE; Al-Lazikani B; Pearl FM
Nat Rev Cancer; 2015 Mar; 15(3):166-80. PubMed ID: 25709118
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in DDR (DNA damage response) inhibitors for cancer therapy.
Cheng B; Pan W; Xing Y; Xiao Y; Chen J; Xu Z
Eur J Med Chem; 2022 Feb; 230():114109. PubMed ID: 35051747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
